Cargando…
Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?
COVID-19 is caused by the Severe Acute Respiratory Syndrome (SARS) coronavirus (Cov)-2, an enveloped virus with a positive-polarity, single-stranded RNA genome. The initial outbreak of the pandemic began in December 2019, and it is affecting the human health of the global community. In common with p...
Autores principales: | Sallenave, Jean-Michel, Guillot, Loïc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270404/ https://www.ncbi.nlm.nih.gov/pubmed/32574272 http://dx.doi.org/10.3389/fimmu.2020.01229 |
Ejemplares similares
-
Innate and adaptive immunity to SARS-CoV-2 and predisposing factors
por: Shen, Jiaying, et al.
Publicado: (2023) -
Innate Immune Responses by Respiratory Viruses, Including Rhinovirus, During Asthma Exacerbation
por: Nakagome, Kazuyuki, et al.
Publicado: (2022) -
Immune-profiling of SARS-CoV-2 viremic patients reveals dysregulated innate immune responses
por: Sun, Xiaoming, et al.
Publicado: (2022) -
Sex-Related Differences in Innate and Adaptive Immune Responses to SARS-CoV-2
por: Agrawal, Sudhanshu, et al.
Publicado: (2021) -
Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions
por: Abdelmoaty, Mai M., et al.
Publicado: (2021)